331 related articles for article (PubMed ID: 34439796)
1. Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer.
Reang J; Sharma PC; Thakur VK; Majeed J
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439796
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
3. Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations.
Pawlowska E; Szczepanska J; Blasiak J
Oxid Med Cell Longev; 2019; 2019():7286737. PubMed ID: 31934267
[TBL] [Abstract][Full Text] [Related]
4. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug.
Testa U; Pelosi E; Castelli G
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):179-191. PubMed ID: 33278349
[TBL] [Abstract][Full Text] [Related]
5. Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.
Fukumura H; Sato M; Kezuka K; Sato I; Feng X; Okumura S; Fujita T; Yokoyama U; Eguchi H; Ishikawa Y; Saito T
J Physiol Sci; 2012 May; 62(3):251-7. PubMed ID: 22392350
[TBL] [Abstract][Full Text] [Related]
6. Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy.
de Carvalho Melo-Cavalcante AA; da Rocha Sousa L; Alencar MVOB; de Oliveira Santos JV; da Mata AMO; Paz MFCJ; de Carvalho RM; Nunes NMF; Islam MT; Mendes AN; Gonçalves JCR; da Silva FCC; Ferreira PMP; de Castro E Sousaa JM
Biomed Pharmacother; 2019 Jan; 109():1394-1405. PubMed ID: 30551390
[TBL] [Abstract][Full Text] [Related]
7. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
8. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
[TBL] [Abstract][Full Text] [Related]
9. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
10. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
Fischer AP; Miles SL
Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
[TBL] [Abstract][Full Text] [Related]
11. Experimental therapeutics: targeting the redox Achilles heel of cancer.
Cabello CM; Bair WB; Wondrak GT
Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C (Ascorbate) and Redox Topics in Cancer.
Glorieux C; Buc Calderon P
Antioxid Redox Signal; 2021 Nov; 35(14):1157-1175. PubMed ID: 34254829
[No Abstract] [Full Text] [Related]
13. Vitamins C and E: beneficial effects from a mechanistic perspective.
Traber MG; Stevens JF
Free Radic Biol Med; 2011 Sep; 51(5):1000-13. PubMed ID: 21664268
[TBL] [Abstract][Full Text] [Related]
14. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
Elmore AR
Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice.
Campbell EJ; Vissers MCM; Wohlrab C; Hicks KO; Strother RM; Bozonet SM; Robinson BA; Dachs GU
Free Radic Biol Med; 2016 Oct; 99():451-462. PubMed ID: 27567539
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species in redox cancer therapy.
Tong L; Chuang CC; Wu S; Zuo L
Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C - A new player in regulation of the cancer epigenome.
Gillberg L; Ørskov AD; Liu M; Harsløf LBS; Jones PA; Grønbæk K
Semin Cancer Biol; 2018 Aug; 51():59-67. PubMed ID: 29102482
[TBL] [Abstract][Full Text] [Related]
18. The differential role of reactive oxygen species in early and late stages of cancer.
Assi M
Am J Physiol Regul Integr Comp Physiol; 2017 Dec; 313(6):R646-R653. PubMed ID: 28835450
[TBL] [Abstract][Full Text] [Related]
19. ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer.
Wang G; Li Y; Yang Z; Xu W; Yang Y; Tan X
Biochem Biophys Res Commun; 2018 Jun; 500(4):873-878. PubMed ID: 29702094
[TBL] [Abstract][Full Text] [Related]
20. Targeting Production of Reactive Oxygen Species as an Anticancer Strategy.
Marioli-Sapsakou GK; Kourti M
Anticancer Res; 2021 Dec; 41(12):5881-5902. PubMed ID: 34848443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
